NCT02465060 2026-04-13
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
NRG Oncology
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Mayo Clinic
Emory University
University of California, San Francisco
City of Hope Medical Center
Academic and Community Cancer Research United
National Cancer Institute (NCI)